Bicycle Therapeutics (BCYC)
8.99
-0.20 (-2.18%)
At close: Mar 28, 2025, 3:59 PM
8.87
-1.39%
After-hours: Mar 28, 2025, 04:09 PM EDT
Bicycle Therapeutics Income Statement
| Year | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 |
| Revenue | 35.27M | 26.98M | 14.46M | 11.7M | 10.39M | 13.8M | 7.14M | 2.06M | n/a |
| Cost of Revenue | n/a | 6.47M | 3.69M | 44.88M | 33.15M | 25.54M | 20.76M | 11.87M | 269.29K |
| Gross Profit | 35.27M | 20.51M | 10.78M | -33.18M | -22.76M | -11.74M | -13.63M | -9.81M | -269.29K |
| Operating Income | -209.87M | -189.95M | -116.65M | -65.62M | -51.96M | -26.3M | -21.75M | -16.21M | -13.49M |
| Interest Income | 34.28M | 14M | 5.76M | 120K | 683K | 814K | 169K | 50K | 8K |
| Pretax Income | -173.8M | -179.21M | -114.24M | -68.48M | -51.73M | -30.86M | -22.24M | -16.28M | -13.53M |
| Net Income | -169.03M | -180.66M | -112.72M | -66.82M | -51.01M | -30.61M | -21.85M | -16.26M | -13.51M |
| Selling & General & Admin | 72.18M | 59.83M | 49.51M | 32.44M | 29.2M | 14.56M | 8.12M | 6.41M | 3.45M |
| Research & Development | 172.97M | 156.5M | 81.61M | 44.88M | 33.15M | 25.54M | 20.76M | 11.87M | 9.77M |
| Other Expenses | n/a | 594K | n/a | n/a | n/a | -5.38M | -665K | -119K | n/a |
| Operating Expenses | 245.15M | 216.92M | 131.12M | 77.31M | 62.35M | 40.1M | 28.88M | 18.27M | 13.22M |
| Interest Expense | 1.73M | 3.26M | 3.34M | 2.98M | 457K | n/a | n/a | n/a | n/a |
| Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -325.11K |
| Cost & Expenses | 245.15M | 216.92M | 131.12M | 77.31M | 62.35M | 40.1M | 28.88M | 18.27M | 13.49M |
| Income Tax | -4.76M | 1.46M | -1.52M | -1.66M | -724K | -254K | -396K | -23K | -20.94K |
| Shares Outstanding (Basic) | 582.08M | 35.59M | 29.66M | 25.06M | 19.15M | 11.05M | 13.29M | 13.29M | 17.7M |
| Shares Outstanding (Diluted) | 582.08M | 35.59M | 29.66M | 25.06M | 19.15M | 11.05M | 13.29M | 13.29M | 17.7M |
| EPS (Basic) | -0.29 | -5.08 | -3.8 | -2.67 | -2.66 | -2.77 | -1.64 | -1.22 | -0.76 |
| EPS (Diluted) | -0.29 | -5.08 | -3.8 | -2.67 | -2.66 | -2.77 | -1.64 | -1.22 | -0.76 |
| EBITDA | -164.89M | -183.4M | -112.96M | -64.08M | -50.39M | -30.03M | -21.49M | -15.88M | -13.26M |
| Depreciation & Amortization | 7.17M | 6.55M | 3.69M | 1.41M | 1.29M | 963.97K | 710.8K | 335.56K | 269.29K |